Our injectable portfolio includes small molecules, peptides & recombinant proteins. These products would be manufactured in our 'Fill & Finish' sterile plant.
|Octreotide Injection||50, 100, 500mcg/ml single dose (1ml in 2ml Vial)|
|Octreotide Injection||200, 1000mcg/ml Multidose Vial (5ml Vial)|
|Zoledronic Acid Injection||4mg/5ml vial|
|Palonosetron injection||0.25mg/5ml Vial|
|Icatibant Acetate Injection||30mg/ 3ml PFS|
|Peg Filgrastim injection||6mg/0.6m PFS|
|Sugammadex Sodium Injection||100mg/ml - 2ml & 5ml vial|
|Regadenoson Monohydrate Injection||0.4mg/5ml|
|Glycopyrrolate Injection||0.2mg/ml in 1ml, 2ml, 5ml & 20ml vial|
|Etelcalcetide Injection||2.5mg/0.5ml, 5 mg/ml, 10 mg/2ml|
Injectable US: filed 9 ANDAs, 4 approved, 1 launched, 4 under review
Injectable EU/UK: 4 Filed, 3 approved, 1 commercial
Injectable Emerging market: 24 Filed, 11 approved, 8 commercial
For more information about our existing portfolio and our pipeline products please e-mail us at firstname.lastname@example.org
Disclaimer: Products under patents are offered for sale only in those countries where patents have expired.